Pro-inflammatory effect of cystic fibrosis sputum microparticles in the murine lung

Chiara Porro1, Sante Di Gioia, Teresa Trotta

  • 1Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.

Abstract

Insights

Microparticles (MPs) from cystic fibrosis (CF) patients induce lung inflammation. Neutrophil-derived MPs may contribute to CF airway inflammation by binding shed lipopolysaccharide (LPS).

Area of Science:

  • Respiratory Medicine
  • Immunology
  • Cell Biology

Background:

  • The role of microparticles (MPs) in cystic fibrosis (CF) airway inflammation remains unclear.
  • This study investigates the pro-inflammatory potential of CF MPs in an acute lung injury model.

Purpose of the Study:

  • To assess the inflammatory effects of MPs from CF patients compared to primary ciliary diskinesia (PCD) patients.
  • To investigate the lipopolysaccharide (LPS)-like activity of these MPs.

Main Methods:

  • Intratracheal administration of MPs from CF and PCD patients into mice.
  • Evaluation of lung inflammation via histopathology and bronchoalveolar lavage fluid analysis.
  • Limulus amebocyte lysate assay to detect LPS-like activity in MPs.

Main Results:

  • MPs from acute CF patients induced significant peribronchial and perivascular inflammation, similar to LPS.
  • Inflammation induced by CF MPs was granulocyte-dominated and more pronounced than from stable CF patients.
  • PCD MPs induced macrophage-dominated inflammation; LPS-like activity was found in CF sputum MPs and stimulated neutrophils, not circulating CF MPs.

Conclusions:

  • Neutrophil-derived MPs in CF airways may exert pro-inflammatory effects through binding shed LPS.
  • This mechanism highlights a potential pathway for inflammation in CF lung disease.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation